Deguanylylating

Deguanylylating is the enzymatic or chemical removal of a guanylyl group (guanine ribonucleotide, GMP) from a target molecule. The process is analogous to dephosphorylation but involves a guanosine moiety linked by a phosphodiester bond. In primary metabolism, the guanylyl group can be attached to proteins, nucleic acids, or metabolites, influencing their stability and function.

On a chemical level, guanylyl is attached through a 5′–3′ phosphodiester linkage to a ribose of the donor molecule. Deguanylylating enzymes catalyze the hydrolysis of this phosphodiester bond, releasing free guanosine monophosphate and releasing the substrate in a deguanylated state. The reaction typically requires divalent metal ions such as Mg²⁺ or Mn²⁺ as cofactors and proceeds via a Michaelis–Menten kinetic framework.

Known deguanylylases include ribonuclease P and phosphodiesterases that recognize specific guanylylated substrates. In signal transduction, deguanylation of cyclic GMP regulates second‑messenger levels downstream of guanylyl cyclases. Additionally, certain DNA repair pathways involve removal of guanylyl‑modified DNA ends, and RNA modifications such as N6‑methyladenosine can be reversed by deguanylylating activity in stress‑response contexts.

The biological significance of deguanylylating lies in regulating cellular signaling, remodeling of RNA and DNA structures, and controlling protein activity by altering post‑translational modifications. Research into specific deguanylylases is ongoing, with a focus on structural biology to identify active‑site residues and on developing small‑molecule inhibitors that could modulate pathways implicated in cardiovascular disease, cancer, and neurodegeneration.